Richard Glynne
InvestorVenture Partner at Versant Ventures
About
Venture partner at Versant and president and CSO of Versant's Inception Sciences Discovery Engine, with expertise in developing and translating novel therapies. He joined Inception as CSO in 2018 after leading search and evaluation at Novartis and holding research leadership roles at the Genomics Institute of the Novartis Research Foundation, Eos Biotechnology, and Phenomix Corporation; he trained in immunology and genetics at ICRF London and Stanford (HHMI).
Colleagues at Versant Ventures
Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Managing Director at Versant Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures